Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using an animal model involving rats fed tetraethylorthosilicate, the minimal effective dietary concentration of ammonium chloride for reduction of silica
urolithiasis
was determined to be approximately 0.10 equivalents/kg diet.
Ammonium sulfate
appeared to be only slightly less effective. The lower incidences of
urolithiasis
were associated with urinary pH less than 7. A subprophylactic concentration (0.067 equivalents/kg diet) of ammonium chloride was factored with three levels of supplemental phosphorus (0, 0.15 and 0.30%) from Na2HPO4 to determine whether the antiurolithic effects of dietary phosphate and urinary-acidifying salts are synergistic. Phosphate had no effect on urinary pH. A 50% urolith incidence occurred in controls; the incidence was 25% (P = 0.08) with 0.15 and 10% (P less than 0.01) with 0.30% phosphorus. Urinary pH was 7.5 in controls compared with approximately 7.2 in rats given the subprophylactic level of ammonium chloride, but ammonium chloride alone had no effect on
urolithiasis
. However, complete protection from
urolithiasis
was provided by each of the two levels of phosphorus in combination with ammonium chloride. It is concluded that supplemental dietary phosphorus is most effective for protection against silica
urolithiasis
under conditions contributing toward urinary acidification due to a possible synergism between dietary phosphorus and urinary acidifying salts.
...
PMID:A possible synergism of dietary phosphate and urine-acidifying salts in preventing silica urolithiasis in a rat model. 282 Dec 3